Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21 USD | +3.35% | +30.69% | +40.32% |
05-02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
05-02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.32% | 2.19B | |
+73.58% | 12.43B | |
-18.64% | 8.09B | |
-0.40% | 6.12B | |
+14.66% | 5.59B | |
-14.69% | 5.47B | |
+39.93% | 5.23B | |
-16.51% | 4.1B | |
-28.10% | 2.65B | |
+1.36% | 1.99B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Transcript : NovoCure Limited Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 08